the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Heather Humphreys leads Irish presidential race with 22% support in new poll

GENEVA: Former Irish social protection minister Heather Humphreys leads the presidential race according to a new national poll.

The Red C survey for the Business Post shows the Fine Gael candidate securing 22% support among Irish voters.

Fianna Fail candidate Jim Gavin follows in second place with 18% backing from respondents.

Independent candidate Catherine Connolly, supported by left-wing groups, closely trails with 17% support.

More than a third of surveyed voters, representing 36%, remain undecided about their preferred candidate.

The poll reveals significant crossover support between Ireland’s two main centrist political parties.

Nearly 29% of Fianna Fail voters indicated they would give their first preference to Humphreys.

Only 12% of Fine Gael voters said they would support Gavin as their first choice candidate.

Businessman Peter Casey, who previously ran in the 2018 presidential election, received 6% support.

Conservative activist Maria Steen secured 5% backing from those surveyed in the poll.

Independent candidates Nick Delehanty and Gareth Sheridan received 4% and 2% support respectively.

The survey involved 1,003 adults and was conducted between September 4 and September 9 this year.

The poll carries a margin of error of 3% points according to the research methodology. – Bernama-AnadoluIrish Minister for Business, Enterprise & Innovation Heather Humphreys

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings